Everstar Asset Management, LLC Aquestive Therapeutics, Inc. Transaction History
Everstar Asset Management, LLC
- $137 Billion
- Q1 2025
A detailed history of Everstar Asset Management, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Everstar Asset Management, LLC holds 300,000 shares of AQST stock, worth $1.18 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
300,000
Previous 216,223
38.75%
Holding current value
$1.18 Million
Previous $770 Million
13.02%
% of portfolio
0.63%
Previous 0.54%
Shares
3 transactions
Others Institutions Holding AQST
# of Institutions
133Shares Held
44.8MCall Options Held
44.6KPut Options Held
182K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$38.5 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$21.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.07MShares$16 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.73MShares$14.6 Million0.45% of portfolio
-
Geode Capital Management, LLC Boston, MA1.7MShares$6.67 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $209M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...